Have your own idea? Try our Stock Screener
Chinese (SSE) Healthcare Services Industry Analysis
UpdatedAug 31, 2025
DataAggregated Company Financials
Companies40
- 7D-1.5%
- 3M7.6%
- 1Y27.7%
- YTD9.6%
Over the last 7 days, the Healthcare Services industry has dropped 1.5%, driven by a pullback from Huadong Medicine of 2.9%. On the other hand Dian Diagnostics GroupLtd is actually up 9.3%. Over the past 12 months, the industry was up 28%. Looking forward, earnings are forecast to grow by 20% annually.
Industry Valuation and Performance
Has the Chinese Healthcare Services Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 31 Aug 2025 | CN¥615.0b | CN¥987.9b | CN¥20.7b | 31.6x | 29.7x | 0.6x |
| Tue, 29 Jul 2025 | CN¥598.5b | CN¥988.6b | CN¥20.9b | 31.9x | 28.6x | 0.6x |
| Thu, 26 Jun 2025 | CN¥563.9b | CN¥988.6b | CN¥20.9b | 30.4x | 26.9x | 0.6x |
| Sat, 24 May 2025 | CN¥567.4b | CN¥990.9b | CN¥21.0b | 30.8x | 27.1x | 0.6x |
| Mon, 21 Apr 2025 | CN¥555.3b | CN¥987.2b | CN¥20.8b | 29.2x | 26.7x | 0.6x |
| Wed, 19 Mar 2025 | CN¥607.4b | CN¥993.2b | CN¥21.0b | 34.2x | 28.9x | 0.6x |
| Fri, 14 Feb 2025 | CN¥579.6b | CN¥994.3b | CN¥21.5b | 30.5x | 26.9x | 0.6x |
| Sun, 12 Jan 2025 | CN¥533.6b | CN¥994.3b | CN¥21.5b | 27.9x | 24.8x | 0.5x |
| Tue, 10 Dec 2024 | CN¥629.7b | CN¥994.3b | CN¥21.5b | 34.6x | 29.3x | 0.6x |
| Thu, 07 Nov 2024 | CN¥614.2b | CN¥994.3b | CN¥21.5b | 35.6x | 28.6x | 0.6x |
| Sat, 05 Oct 2024 | CN¥626.4b | CN¥984.5b | CN¥22.0b | 37.1x | 28.4x | 0.6x |
| Mon, 02 Sep 2024 | CN¥479.5b | CN¥984.3b | CN¥22.2b | 24.8x | 21.6x | 0.5x |
| Wed, 31 Jul 2024 | CN¥487.4b | CN¥988.5b | CN¥22.5b | 25.9x | 21.7x | 0.5x |
| Fri, 28 Jun 2024 | CN¥502.0b | CN¥988.5b | CN¥22.5b | 27.2x | 22.3x | 0.5x |
| Sun, 26 May 2024 | CN¥568.6b | CN¥988.5b | CN¥22.5b | 32.6x | 25.3x | 0.6x |
| Tue, 23 Apr 2024 | CN¥568.1b | CN¥985.8b | CN¥20.2b | 29.2x | 28.1x | 0.6x |
| Thu, 21 Mar 2024 | CN¥624.3b | CN¥977.8b | CN¥20.1b | 30.2x | 31.1x | 0.6x |
| Sat, 17 Feb 2024 | CN¥603.7b | CN¥977.8b | CN¥20.1b | 29.1x | 30x | 0.6x |
| Mon, 15 Jan 2024 | CN¥639.7b | CN¥976.7b | CN¥19.7b | 28.5x | 32.5x | 0.7x |
| Wed, 13 Dec 2023 | CN¥697.1b | CN¥976.1b | CN¥19.9b | 31x | 35x | 0.7x |
| Fri, 10 Nov 2023 | CN¥731.9b | CN¥976.1b | CN¥19.9b | 31.9x | 36.7x | 0.7x |
| Sun, 08 Oct 2023 | CN¥733.8b | CN¥982.2b | CN¥21.2b | 29.8x | 34.6x | 0.7x |
| Tue, 05 Sep 2023 | CN¥734.5b | CN¥982.1b | CN¥21.2b | 29.7x | 34.7x | 0.7x |
| Thu, 03 Aug 2023 | CN¥760.7b | CN¥954.7b | CN¥23.1b | 25.6x | 32.9x | 0.8x |
| Sat, 01 Jul 2023 | CN¥781.5b | CN¥948.1b | CN¥23.0b | 26.4x | 34x | 0.8x |
| Mon, 29 May 2023 | CN¥824.6b | CN¥948.0b | CN¥23.0b | 27.2x | 35.9x | 0.9x |
| Wed, 26 Apr 2023 | CN¥816.9b | CN¥917.3b | CN¥26.9b | 30.5x | 30.4x | 0.9x |
| Fri, 24 Mar 2023 | CN¥827.4b | CN¥906.1b | CN¥26.8b | 31.2x | 30.8x | 0.9x |
| Sun, 19 Feb 2023 | CN¥854.4b | CN¥906.0b | CN¥26.4b | 31.5x | 32.4x | 0.9x |
| Tue, 17 Jan 2023 | CN¥854.4b | CN¥905.7b | CN¥26.4b | 30.5x | 32.4x | 0.9x |
| Thu, 15 Dec 2022 | CN¥796.4b | CN¥905.7b | CN¥26.4b | 29.4x | 30.2x | 0.9x |
| Sat, 12 Nov 2022 | CN¥752.8b | CN¥905.7b | CN¥26.4b | 31.6x | 28.6x | 0.8x |
| Mon, 10 Oct 2022 | CN¥654.9b | CN¥842.5b | CN¥23.8b | 21x | 27.5x | 0.8x |
| Wed, 07 Sep 2022 | CN¥669.4b | CN¥842.5b | CN¥23.8b | 24.5x | 28.1x | 0.8x |
Price to Earnings Ratio
28.1x
Current Industry PE
- Investors are relatively neutral on the Chinese Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 29.4x.
- The industry is trading close to its 3-year average PS ratio of 0.69x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have declined 4.6% per year over the last three years.
- Meanwhile revenues for these companies have grown 5.5% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the Chinese Healthcare industry?
| CN Market | 1.78% | |
| Healthcare | -0.87% | |
| Healthcare Services | -1.54% | |
| Healthcare Services | -0.32% | |
| Healthcare Facilities | -0.72% | |
| Healthcare Distributors | -2.37% | |
Industry PE
- Investors are most optimistic about the Healthcare Services industry which is trading above its 3-year average PE ratio of 76.1x.
- Analysts are expecting annual earnings growth of 44.1%, which is higher than its past year's earnings decline of 14.2% per year.
- Investors are most pessimistic about the Healthcare Distributors industry, which is trading close to its 3-year average of 19.1x.
Forecasted Growth
- Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 44% over the next 5 years.
- This is better than its past earnings decline of 14% per year.
- In contrast, the Healthcare Distributors industry is expected to see its earnings grow by 12% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 300244 Dian Diagnostics GroupLtd | CN¥18.15 | 9.3% +CN¥947.2m | 72.4% | PS1x | |
| 301015 Qingdao Baheal Medical | CN¥26.40 | 6.2% +CN¥809.5m | 14.2% | PE23.5x | |
| 600211 Tibet Rhodiola Pharmaceutical Holding | CN¥47.16 | 2.4% +CN¥361.0m | 35.8% | PE15.1x | |
| 600763 Topchoice Medical | CN¥47.14 | 0.9% +CN¥178.9m | 8.6% | PE41.1x | |
| 603882 Guangzhou Kingmed Diagnostics Group | CN¥31.95 | 1.2% +CN¥176.0m | 16.1% | PS2.3x |